scholarly article | Q13442814 |
P2093 | author name string | Bergeron J | |
Alméras N | |||
Després JP | |||
Nadeau A | |||
Bogaty P | |||
Lemieux I | |||
Pascot A | |||
Prud'homme D | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | obesity | Q12174 |
P304 | page(s) | 961-967 | |
P577 | publication date | 2001-06-01 | |
P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
P1476 | title | Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity | |
P478 | volume | 21 |
Q36641503 | 'Metabolically healthy obesity': origins and implications |
Q43165906 | A 52-week prospective, cohort study of the effects of losartan with or without hydrochlorothiazide (HCTZ) in hypertensive patients with metabolic syndrome |
Q37620043 | A Useful Tool As a Medical Checkup in a General Population-Bioelectrical Impedance Analysis |
Q38076251 | A consideration of biomarkers to be used for evaluation of inflammation in human nutritional studies |
Q35711283 | A novel anti-inflammatory natural product from Sphaeranthus indicus inhibits expression of VCAM1 and ICAM1, and slows atherosclerosis progression independent of lipid changes |
Q36822591 | Abdominal Obesity and Association With Atherosclerosis Risk Factors: The Uberlândia Heart Study. |
Q36682671 | Abdominal obesity and metabolic syndrome |
Q46422661 | Abdominal obesity predicts declining insulin sensitivity in non-obese normoglycaemics: the Insulin Resistance Atherosclerosis Study (IRAS). |
Q37267248 | Abdominal obesity: the cholesterol of the 21st century? |
Q34551435 | Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study |
Q42953757 | Acute resistance exercise results in catecholaminergic rather than hypothalamic-pituitary-adrenal axis stimulation during exercise in young men. |
Q54597679 | Adipocytokines in rheumatoid arthritis and obesity |
Q33835439 | Adipokines are associated with lower extremity venous disease: the San Diego population study. |
Q34384883 | Adipokines: molecular links between obesity and atheroslcerosis |
Q51921520 | Adiponectin gene expression and adipocyte NF-kappaB transcriptional activity in elderly overweight and obese women: inter-relationships with fat distribution, hs-CRP, leptin and insulin resistance. |
Q38220213 | Adipose tissue changes in obesity and the impact on metabolic function |
Q52558707 | An integrative approach to investigate the association among high-sensitive C-reactive protein, body fat mass distribution, and other cardiometabolic risk factors in young healthy women. |
Q37578266 | Appropriateness of waist circumference and waist-to-hip ratio cutoffs for different ethnic groups |
Q34388277 | Are risk factors associated with outcomes in pancreatic cancer? |
Q34974413 | Association between Abdominal Fat (DXA) and Its Subcomponents (CT Scan) before and after Weight Loss in Obese Postmenopausal Women: A MONET Study |
Q44684059 | Association between C-reactive protein, anthropometric and lipid parameters among healthy normal weight and overweight postmenopausal women in Montenegro |
Q44713977 | Association between fasting glucose and C-reactive protein in middle-aged subjects |
Q35717014 | Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study |
Q39721292 | Association of C-reactive protein with body fat, diabetes and coronary artery disease in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-6). |
Q30355036 | Association of Central Adiposity With Adverse Cardiac Mechanics: Findings From the Hypertension Genetic Epidemiology Network Study. |
Q37261739 | Association of obesity-mediated insulin resistance and hypothalamic volumes: possible sex differences. |
Q44768008 | Associations among work-related stress, cortisol, inflammation, and metabolic syndrome. |
Q33938878 | Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training |
Q36381096 | Biomarkers of obesity and subsequent cardiovascular events |
Q92462247 | Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis |
Q33630100 | Biphasic response of mitochondrial biogenesis to oxidative stress in visceral fat of diet-induced obesity mice |
Q44969867 | Body fat and C-reactive protein levels in healthy non-obese men. |
Q34985484 | Body fat distribution and inflammation among obese older adults with and without metabolic syndrome |
Q42366197 | Body fat distribution, in particular visceral fat, is associated with cardiometabolic risk factors in obese women |
Q34062129 | Brain, liver, and serum salusin-alpha and -beta alterations in Sprague-Dawley rats with or without metabolic syndrome |
Q38473714 | Bringing JUPITER down to earth |
Q47182880 | C-reactive protein and coronary artery disease: influence of obesity, caloric restriction and weight loss |
Q46044968 | C-reactive protein and tumor necrosis factor-alpha in relation to insulin-mediated glucose uptake, smoking and atherosclerosis |
Q44594411 | C-reactive protein in young, apparently healthy men: associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol |
Q46406619 | C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study |
Q46595366 | CRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects |
Q45286980 | CRP: star trekking the galaxy of risk markers |
Q51497326 | Calcium supplementation does not affect CRP levels in postmenopausal women--a randomized controlled trial. |
Q36957415 | Cardiovascular Risk in Women With PCOS. |
Q36662926 | Challenges associated with metabolic syndrome |
Q64100119 | Change in Plant-Based Diet Quality Is Associated with Changes in Plasma Adiposity-Associated Biomarker Concentrations in Women |
Q35660000 | Changes in erythrocyte sedimentation rate, white blood cell count, liver enzymes, and magnesium after gastric bypass surgery |
Q37849235 | Chronic inflammation is correlated with percentage of body fat independent of the burden of infection |
Q47760005 | Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort. |
Q36550333 | Chronic sub-clinical inflammation in the abdominal adipose tissue - Evaluation of inflammatory cytokines and their link with insulin resistance in metabolically obese South Indians: A cross-sectional observational study |
Q47185422 | Claimed effects, outcome variables and methods of measurement for health claims on foods proposed under European Community Regulation 1924/2006 in the area of appetite ratings and weight management |
Q31140518 | Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots |
Q46163361 | Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalisation of plasma testosterone levels in hypogonadal elderly men. |
Q36434450 | Contribution of CB1 blockade to the management of high-risk abdominal obesity |
Q55263145 | Coronary Disease and Metabolic Syndrome. |
Q57761427 | Diabetes y enfermedad cardiovascular |
Q42592049 | Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice |
Q37349807 | Dietary determinants of subclinical inflammation, dyslipidemia and components of the metabolic syndrome in overweight children: a review |
Q46496031 | Direct comparison of dietary portfolio vs statin on C-reactive protein |
Q31113992 | Does body mass index (BMI) influence the Ankylosing Spondylitis Disease Activity Score in axial spondyloarthritis?: Data from the SPACE cohort |
Q38261196 | Ectopic visceral fat: a clinical and molecular perspective on the cardiometabolic risk |
Q55395282 | Effect of 8 Weeks Soccer Training on Health and Physical Performance in Untrained Women. |
Q36929124 | Effect of Acupuncture on Body Weight Reduction and Inflammatory Mediators in Egyptian Obese Patients |
Q37352857 | Effect of exercise on abdominal fat loss in men and women with and without type 2 diabetes |
Q35441429 | Effect of increased leptin and C-reactive protein levels on mortality: results from the National Health and Nutrition Examination Survey |
Q42164961 | Effect of insulin therapy on endothelium-dependent dilation in type 2 diabetes mellitus |
Q46948236 | Effectiveness of weight loss in the elderly with type 2 diabetes mellitus |
Q36941827 | Effects of Low-Fat Diets Differing in Protein and Carbohydrate Content on Cardiometabolic Risk Factors during Weight Loss and Weight Maintenance in Obese Adults with Type 2 Diabetes |
Q28297798 | Effects of exercise and diet on chronic disease |
Q33708384 | Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients |
Q38454661 | Effects of simvastatin on C-reactive protein in mixed hyperlipidemic and hypertriglyceridemic patients |
Q36216863 | Effects of weight loss and pharmacotherapy on inflammatory markers of cardiovascular disease |
Q44479466 | Elevated concentrations of C-reactive protein in subjects with type 2 diabetes mellitus are moderately influenced by glycemic control |
Q48025354 | Endogenous thrombin potential in polycystic ovary syndrome: the association to body mass index, insulin resistance, and inflammation. |
Q35087494 | Endothelial dysfunction and the metabolic syndrome |
Q35813629 | Endothelial dysfunction, inflammation and diabetes |
Q51489577 | Endothelial lipase is associated with inflammation in humans. |
Q44360330 | Enhanced erythrocyte adhesiveness/aggregation in obesity corresponds to low-grade inflammation. |
Q84644791 | Evaluation of lasting high levels of CRP among the patients with metabolic syndrome |
Q35201559 | Evaluation of the combined use of adiponectin and C-reactive protein levels as biomarkers for predicting the deterioration in glycaemia after a median of 5.4 years |
Q36815079 | FUNCTIONAL HYPERCORTISOLISM, VISCERAL OBESITY, AND METABOLIC SYNDROME. |
Q80827639 | Flow-resistant red blood cell aggregation in morbid obesity |
Q55424979 | Gemcabene, a First-in-Class Hypolipidemic Small Molecule in Clinical Development, Attenuates Osteoarthritis and Pain in Animal Models of Arthritis and Pain. |
Q52592593 | Gemcabene, a first-in-class lipid-lowering agent in late-stage development, down-regulates acute-phase C-reactive protein via C/EBP-δ-mediated transcriptional mechanism. |
Q53198210 | Genetic contribution to C-reactive protein levels in severe obesity. |
Q34270507 | Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women |
Q51449727 | Genome-wide linkage analysis for circulating levels of adipokines and C-reactive protein in the Quebec family study (QFS). |
Q52948768 | Haemostatic and inflammatory alterations in familial hypercholesterolaemia, and the impact of angiotensin II infusion. |
Q34454547 | Health consequences of visceral obesity |
Q35197824 | Health risks of lipodystrophy and abdominal fat accumulation: therapeutic possibilities with leptin and human growth hormone |
Q45848309 | Hepatocyte growth factor and interferon-γ inducible protein-10 are related to visceral adiposity. |
Q50057787 | Hepatocyte nuclear factors as possible C-reactive protein transcriptional inducer in the liver and white adipose tissue of rats with experimental chronic renal failure. |
Q44477341 | High expression of complement components in omental adipose tissue in obese men. |
Q51483133 | Hip circumference is an important predictor of plasma C-reactive protein levels in overweight and obese Taiwanese women. |
Q37364955 | Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes |
Q92378297 | Impact of Estrogens on the Regulation of White, Beige, and Brown Adipose Tissue Depots |
Q30309693 | Impact of the GH-cortisol ratio on the age-dependent changes in body composition |
Q35078877 | Impact of weight loss diet associated with flaxseed on inflammatory markers in men with cardiovascular risk factors: a clinical study |
Q51326584 | Improvement of atherosclerotic markers in non-diabetic patients after bariatric surgery. |
Q35707614 | Inflammation and race and gender differences in computerized tomography-measured adipose depots |
Q37198826 | Inflammation as a cardiovascular risk factor and pulse wave velocity as a marker of early-stage atherosclerosis in the Japanese population |
Q34578077 | Interactions between C-reactive protein genotypes with markers of nutritional status in relation to inflammation |
Q73392899 | Interpretation of circulating C-reactive protein levels in adults: Body Mass Index and gender are a must |
Q64096918 | Interrelation of chemerin and TNF-α with mtDNA copy number in adipose tissues and blood cells in obese patients with and without type 2 diabetes |
Q24796491 | Intimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy |
Q48110940 | Intrauterine growth restriction combined with a maternal high-fat diet increased adiposity and serum corticosterone levels in adult rat offspring |
Q44075438 | Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors. |
Q36070412 | Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis |
Q61449481 | Lipid Oxidation Assessed by Indirect Calorimetry Predicts Metabolic Syndrome and Type 2 Diabetes |
Q44898907 | Low-grade systemic inflammation impairs arterial stiffness in newly diagnosed hypercholesterolaemia |
Q34248896 | Lymphatic system: a vital link between metabolic syndrome and inflammation |
Q64087695 | Metabolic Risk Factors and Left Ventricular Diastolic Function in Middle-Aged Chinese Living in the Tibetan Plateau |
Q34643136 | Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trial |
Q34287907 | Metabolic health reduces risk of obesity-related cancer in framingham study adults |
Q53621412 | Metabolic syndrome aggravates the increased endothelial activation and low-grade inflammation in subjects with familial low HDL. |
Q34031701 | Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training |
Q36012953 | Metabolic syndrome: the danger signal in atherosclerosis |
Q47217380 | MiR-27b-3p Regulation in Browning of Human Visceral Adipose Related to Central Obesity. |
Q39622961 | Morphological Changes in the Carotid Artery Intima after Gastric Bypass for Morbid Obesity. |
Q34149741 | Novel anti-adipogenic activity produced by human fibroblasts. |
Q92024524 | Nutrition Therapy in Managing Pregnant Women With Gestational Diabetes Mellitus: A Literature Review |
Q28079661 | Nutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndrome |
Q37604873 | Nutritional programming of the metabolic syndrome |
Q22252221 | Obesity and Thrombosis |
Q37352219 | Obesity and inflammation: the effects of weight loss |
Q76394099 | Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome |
Q37455451 | Obesity, coffee consumption and CRP levels in postmenopausal overweight/obese women: importance of hormone replacement therapy use. |
Q44279278 | Obesity, fasting plasma insulin, and C-reactive protein levels in healthy children |
Q36053970 | Obesity, lutein metabolism, and age-related macular degeneration: a web of connections |
Q81585501 | Obesity-related correlation between C-reactive protein and the calculated 10-y Framingham Coronary Heart Disease Risk Score |
Q38200416 | Our stolen figures: the interface of sexual differentiation, endocrine disruptors, maternal programming, and energy balance |
Q51498823 | Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency. |
Q92083501 | Physical Activity, Cardiorespiratory Fitness, and the Metabolic Syndrome |
Q33594449 | Physical exercise reduces the expression of RANTES and its CCR5 receptor in the adipose tissue of obese humans |
Q73588894 | Plasma C-reactive protein concentrations in relation to 5-year body weight change among children: the Taipei Children Heart Study |
Q47313074 | Platelet Counts and Liver Enzymes After Gastric Bypass Surgery. |
Q36663553 | Platelet counts and liver enzymes after bariatric surgery |
Q50728522 | Polycystic ovary syndrome and low-grade inflammation with special reference to YKL-40. |
Q51487065 | Postprandial variations of plasma inflammatory markers in abdominally obese men. |
Q61799934 | Potential impact of the joint association of total bilirubin and gamma-glutamyltransferase with metabolic syndrome |
Q91386621 | Predicting longevity using metabolomics: a novel tool for precision lifestyle medicine? |
Q36342333 | Prediction of metabolic syndrome among postmenopausal Ghanaian women using obesity and atherogenic markers |
Q33627755 | Regression models for log-normal data: comparing different methods for quantifying the association between abdominal adiposity and biomarkers of inflammation and insulin resistance |
Q47703503 | Regression of Left Ventricular Mass After Bariatric Surgery |
Q35582574 | Relation between C reactive protein concentrations and coronary microvascular endothelial function |
Q34247249 | Relation between abdominal subcutaneous fat tissue thickness and inflammatory markers during pregnancy |
Q73107480 | Relation of waist circumference and glycemic status to C-reactive protein in the Sandy Lake Oji-Cree |
Q40728311 | Relations of Visceral and Abdominal Subcutaneous Adipose Tissue, Body Mass Index, and Waist Circumference to Serum Concentrations of Parameters of Chronic Inflammation |
Q44916969 | Relationship between C-reactive protein and visceral adipose tissue in healthy Japanese subjects |
Q48698039 | Relationship between high-sensitivity C-reactive protein and risk factors in patients with peripheral arterial disease--a cross-sectional study |
Q34315210 | Relationship between lung function and metabolic syndrome |
Q35904825 | Role of fibric acid derivatives in the management of risk factors for coronary heart disease |
Q24594814 | Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective |
Q46465988 | Serum C-reactive protein and white blood cell count in morbidly obese surgical patients |
Q37445314 | Serum C-reactive protein levels in normal-weight polycystic ovary syndrome |
Q64890713 | Serum Uric Acid in Roma and Non-Roma-Its Correlation with Metabolic Syndrome and Other Variables. |
Q37061136 | Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner |
Q43917196 | Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial |
Q47131035 | Sonographically Assessed Intra-Abdominal Fat And Cardiometabolic Risk Factors in Adolescents with Extreme Obesity |
Q46866093 | Stress-induced cytokine responses and central adiposity in young women |
Q64998533 | Study of Visceral and Subcutaneous Abdominal Fat Thickness and Its Correlation with Cardiometabolic Risk Factors and Hormonal Parameters in Polycystic Ovary Syndrome. |
Q57303564 | The TNF-α G-308A polymorphism is associated with C-reactive protein levels: The HERITAGE Family Study |
Q48191813 | The association between obesity and fluid intelligence impairment is mediated by chronic low-grade inflammation |
Q90116661 | The association of wrist circumference with hypertension in northeastern Chinese residents in comparison with other anthropometric obesity indices |
Q37209774 | The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology |
Q57892545 | The effects of body acupuncture on obesity: anthropometric parameters, lipid profile, and inflammatory and immunologic markers |
Q35896629 | The epidemiology of central fat distribution in relation to disease |
Q35146626 | The interaction of adiposity with the CRP gene affects CRP levels: age, gene/environment susceptibilty-Reykjavik study |
Q40908186 | The interrelationships of birthweight, inflammation and body composition in healthy adults |
Q51362473 | The relationship between high-sensitivity C-reactive protein and ApoB, ApoB/ApoA1 ratio in general population of China. |
Q48316328 | The relationship between high-sensitivity C-reactive protein levels and the severity of obstructive sleep apnea |
Q46978063 | The role of declining adaptive homeostasis in ageing |
Q36859053 | The usefulness of circulating adipokine levels for the assessment of obesity-related health problems |
Q35046184 | Time-dependent effects of safflower oil to improve glycemia, inflammation and blood lipids in obese, post-menopausal women with type 2 diabetes: a randomized, double-masked, crossover study |
Q33840362 | Toll-like receptor 4 modulates skeletal muscle substrate metabolism |
Q44529498 | Treatment of obesity: the need to target attention on high-risk patients characterized by abdominal obesity |
Q53951145 | Tumour necrosis factor-alpha plasma levels in elderly patients with Type 2 diabetes mellitus-observations over 2 years. |
Q92107971 | Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links |
Q36204530 | Urinary Malondialdehyde Is Associated with Visceral Abdominal Obesity in Middle-Aged Men |
Q43168054 | Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients |
Q46025734 | Visceral adiposity and leptin are independently associated with C-reactive protein in Korean type 2 diabetic patients. |
Q44570728 | Visceral fat accumulation determines postprandial lipemic response, lipid peroxidation, DNA damage, and endothelial dysfunction in nonobese Korean men. |
Q40070943 | Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. |
Q47273955 | Waist circumference in determining obesity and hypertension among 18-60 years old Bengalee Hindu male slum dwellers in Eastern India |
Q44548928 | Weight loss reduces tissue factor in morbidly obese patients |
Search more.